Paul Denslow

Paul Denslow is currently the Board Chair, CEO & Co-Founder, and Board Member at Intus Bio. He is also the Founder of Canford Partners, where he is involved in investing, syndication, consultancy, and fundraising across bio-tech and technology. Additionally, Paul serves as an Advisor for Modulo Bio, CytoVeris, and Quidient. He is also the President of Williams Land Corporation. With a background in finance, Paul has previously worked at companies like Standard Chartered Bank and HSBC in various senior roles. He holds a Bachelor of Science degree in Economics from the University of Bath.